Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 205,599,188 papers from all fields of science
Search
Sign In
Create Free Account
Galantamine
Known as:
Galanthamine
, Lycoremine
, Galantamine [Chemical/Ingredient]
Expand
A benzazepine derived from norbelladine. It is found in GALANTHUS and other AMARYLLIDACEAE. It is a cholinesterase inhibitor that has been used to…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
32 relations
24 HR galantamine hydrobromide 16 MG Extended Release Oral Capsule [Razadyne]
24 HR galantamine hydrobromide 8 MG Extended Release Oral Capsule
Alzheimer's Disease
Galantamine 8 MG Oral Tablet
Expand
Broader (5)
Alkaloids
Amines
Cholinesterase Inhibitors
Nootropic Agents
Expand
Narrower (9)
Galantamine Hydrochloride
Nivaline
Razadyne
apogalanthamine
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
A review on Alzheimer's disease pathophysiology and its management: an update.
Anil Kumar
,
Arti Singh
,
Ekavali
Pharmacological reports : PR
2015
Corpus ID: 25702304
Review
2008
Review
2008
Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer’s disease: A systematic review and meta-analysis
R. Hansen
,
G. Gartlehner
,
Aaron P Webb
,
L. Morgan
,
C. Moore
,
D. Jonas
Clinical interventions in aging
2008
Corpus ID: 13482579
Pharmacologic treatments for Alzheimer’s disease include the cholinesterase inhibitors donepezil, galantamine, and rivastigmine…
Expand
Review
2005
Review
2005
Drug discovery from medicinal plants.
Marcy J. Balunas
,
A. Kinghorn
Life sciences
2005
Corpus ID: 17797428
Highly Cited
2003
Highly Cited
2003
Galantamine Is an Allosterically Potentiating Ligand of Neuronal Nicotinic but Not of Muscarinic Acetylcholine Receptors
M. Samochocki
,
Anja Höffle
,
+10 authors
A. Maelicke
Journal of Pharmacology and Experimental…
2003
Corpus ID: 18399555
Galantamine (Reminyl), an approved treatment for Alzheimer's disease (AD), is a potent allosteric potentiating ligand (APL) of…
Expand
Review
2003
Review
2003
Treatment of Alzheimer's disease; current status and new perspectives
E. Scarpini
,
Philip Schelterns
,
H. Feldman
The Lancet Neurology
2003
Corpus ID: 33883370
Highly Cited
2002
Highly Cited
2002
Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial
T. Erkinjuntti
,
A. Kurz
,
S. Gauthier
,
R. Bullock
,
S. Lilienfeld
,
C. Damaraju
The Lancet
2002
Corpus ID: 1172847
Highly Cited
2000
Highly Cited
2000
Galantamine in AD
M. Raskind
,
E. Peskind
,
T. Wessel
,
W. Yuan
Neurology
2000
Corpus ID: 41380771
Background: Galantamine is a reversible, competitive cholinesterase inhibitor that also allosterically modulates nicotinic…
Expand
Highly Cited
2000
Highly Cited
2000
A 5-month, randomized, placebo-controlled trial of galantamine in AD
P. Tariot
,
P. Solomon
,
J. Morris
,
P. Kershaw
,
S. Lilienfeld
,
C. Ding
Neurology
2000
Corpus ID: 38335268
Objective: To investigate the efficacy and tolerability of galantamine, using a slow dose escalation schedule of up to 8 weeks…
Expand
Highly Cited
2000
Highly Cited
2000
Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial
G. Wilcock
,
S. Lilienfeld
,
E. Gaens
BMJ : British Medical Journal
2000
Corpus ID: 42073404
Abstract Objective: To evaluate the efficacy and safety of galantamine in the treatment of Alzheimer's disease. Design…
Expand
Review
2000
Review
2000
Galantamine: a review of its use in Alzheimer's disease.
L. Scott
,
K. Goa
Drugs
2000
Corpus ID: 195694183
UNLABELLED Currently, acetylcholinesterase (AChE) inhibitors are the most promising class of drugs for the treatment of Alzheimer…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE